Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 2003

View Archived Issues

Antiobesity effects of IL-6 in rodents

Anti-HIV effects described for green tea component

Antiinflammatory activity of AVR-118 demonstrated in animal model and clinical trial

MMV, Immtech and U. of North Carolina to develop DB-289 for malaria

GW-873140 completes phase I testing

Development agreement for MDTS formulations of Nestorone

Protherics: six-month progress report

Factor Xa inhibitor from Lilly/Tularik collaboration enters phase II

Enrollment to begin in phase I/II trial of CB-001

Novel peptide deformylase inhibitor drug candidate enters phase I

Indena claims two series of hyperforin derivatives for depression and AD

Novel antimycobacterial agents designed at U. of Central Florida

New prodrugs of LY-293558 with AMPA- and GluR5-antagonist activity covered by Lilly patent

New NR2B NMDA antagonist and its use reported by Pfizer team

Altana describes dual NO-donating gastric antisecretory agents

Novel cysteine protease inhibitors in early development at Ono

Isatoribine biologically active in HCV patients in phase Ib trial

Cyclacel acquires rights to CYC-682

EHT-0202 enters phase I study

Risperdal approved for bipolar mania

Binodenoson enters phase III

Avastin submitted for approval in Europe for colorectal cancer

Fast track status granted for HspE7 in recurrent respiratory papillomatosis

Dual-acting estrogen sulfatase inhibitor and SERM presented in San Antonio

JNJ-6368661 characterized as potent, orally active anticoagulant and antithrombotic agent

Selective platelet TP receptor antagonist BM-613 synthesized by Belgian researchers

S-40503: a novel SARM with selective effects on bone in rat models of osteoporosis

hTERT-based vaccine approaches to breast cancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...